Cathie's Ark LogoCathie's Ark
BEGIN TYPING TO SEARCH BY TICKER
Trading Floor Community IconFrom the Trading Floor:
Twist Bioscience Corp Logo

CTRU Holdings of Twist Bioscience (TWST) - Updated Daily

Lock IconJoin Premium Plan

Key Statistics

Upcoming EarningsSee Full Calendar
DateAugust 04, 2022(Est)Revenue
Expected$51.74m
Actualโ–ซ๏ธ
EPS
Expected-$1.32
Actualโ–ซ๏ธ
๐Ÿ•ต๐ŸผFound In๐ŸทLast Price
ARKGARKKCTRU$37.08
โš–๏ธWeighting๐ŸงขMarket Cap
0.74%$2.09b
๐Ÿ’ณARK Estimated Cost Average๐ŸงฎPrice to Sales
12.79
๐ŸŽซARK Ownership Percent๐ŸŒCountry
0.01%๐Ÿ‡บ๐Ÿ‡ธUnited States
Description
Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by 'writing' DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.
Website
www.twistbioscience.com

Research Notes and Commentary for TWST